BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 20218622)

  • 1. 3'-[4-Aryl-(1,2,3-triazol-1-yl)]-3'-deoxythymidine analogues as potent and selective inhibitors of human mitochondrial thymidine kinase.
    Van Poecke S; Negri A; Gago F; Van Daele I; Solaroli N; Karlsson A; Balzarini J; Van Calenbergh S
    J Med Chem; 2010 Apr; 53(7):2902-12. PubMed ID: 20218622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N1-substituted thymine derivatives as mitochondrial thymidine kinase (TK-2) inhibitors.
    Hernandez AI; Familiar O; Negri A; Rodríguez-Barrios F; Gago F; Karlsson A; Camarasa MJ; Balzarini J; Pérez-Pérez MJ
    J Med Chem; 2006 Dec; 49(26):7766-73. PubMed ID: 17181158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human mitochondrial thymidine kinase is selectively inhibited by 3'-thiourea derivatives of beta-thymidine: identification of residues crucial for both inhibition and catalytic activity.
    Balzarini J; Van Daele I; Negri A; Solaroli N; Karlsson A; Liekens S; Gago F; Van Calenbergh S
    Mol Pharmacol; 2009 May; 75(5):1127-36. PubMed ID: 19233899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, modeling and evaluation of 3'-(1-aryl-1H-tetrazol-5-ylamino)-substituted 3'-deoxythymidine derivatives as potent and selective human mitochondrial thymidine kinase inhibitors.
    Van Poecke S; Negri A; Janssens J; Solaroli N; Karlsson A; Gago F; Balzarini J; Van Calenbergh S
    Org Biomol Chem; 2011 Feb; 9(3):892-901. PubMed ID: 21127790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rational design and 3D-pharmacophore mapping of 5'-thiourea-substituted alpha-thymidine analogues as mycobacterial TMPK inhibitors.
    Andrade CH; Pasqualoto KF; Ferreira EI; Hopfinger AJ
    J Chem Inf Model; 2009 Apr; 49(4):1070-8. PubMed ID: 19296716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding the binding of 5-substituted 2'-deoxyuridine substrates to thymidine kinase of herpes simplex virus type-1.
    De Winter H; Herdewijn P
    J Med Chem; 1996 Nov; 39(24):4727-37. PubMed ID: 8941385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and enzymatic activity of highly selective human mitochondrial thymidine kinase inhibitors.
    Manfredini S; Baraldi PG; Durini E; Porcu L; Angusti A; Vertuani S; Solaroli N; De Clercq E; Karlsson A; Balzarini J
    Bioorg Med Chem Lett; 2001 May; 11(10):1329-32. PubMed ID: 11392548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3'-(1,2,3-Triazol-1-yl)-3'-deoxythymidine analogs as substrates for human and Ureaplasma parvum thymidine kinase for structure-activity investigations.
    Lin J; Roy V; Wang L; You L; Agrofoglio LA; Deville-Bonne D; McBrayer TR; Coats SJ; Schinazi RF; Eriksson S
    Bioorg Med Chem; 2010 May; 18(9):3261-9. PubMed ID: 20378362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The design, synthesis and properties of highly potent and selective inhibitors of herpes simplex virus types 1 and 2 thymidine kinase.
    Martin JA; Thomas GJ; Merrett JH; Lambert RW; Bushnell DJ; Dunsdon SJ; Freeman AC; Hopkins RA; Johns IR; Keech E; Simmonite H; Kai-In PW; Holland M
    Antivir Chem Chemother; 1998 Jan; 9(1):1-8. PubMed ID: 9875371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations distal to the substrate site can affect varicella zoster virus thymidine kinase activity: implications for drug design.
    El Omari K; Liekens S; Bird LE; Balzarini J; Stammers DK
    Mol Pharmacol; 2006 Jun; 69(6):1891-6. PubMed ID: 16556772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and evaluation of thymine-derived carboxamides against mitochondrial thymidine kinase (TK-2) and related enzymes.
    Priego EM; Balzarini J; Karlsson A; Camarasa MJ; Pérez-Pérez MJ
    Bioorg Med Chem; 2004 Oct; 12(19):5079-90. PubMed ID: 15351391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2'-O-Acyl/alkyl-substituted arabinosyl nucleosides as inhibitors of human mitochondrial thymidine kinase.
    Balzarinia J; Degrève B; Zhu C; Durini E; Porcu L; De Clercq E; Karlsson A; Manfredini S
    Biochem Pharmacol; 2001 Mar; 61(6):727-32. PubMed ID: 11266658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving the selectivity of acyclic nucleoside analogues as inhibitors of human mitochondrial thymidine kinase: replacement of a triphenylmethoxy moiety with substituted amines and carboxamides.
    Hernández AI; Balzarini J; Rodríguez-Barrios F; San-Félix A; Karlsson A; Gago F; Camarasa MJ; Pérez-Pérez MJ
    Bioorg Med Chem Lett; 2003 Sep; 13(18):3027-30. PubMed ID: 12941326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel ribofuranosylnucleoside lead compounds for potent and selective inhibitors of mitochondrial thymidine kinase-2.
    Balzarini J; Zhu C; De Clercq E; Pérez-Pérez MJ; Chamorro C; Camarasa MJ; Karlsson A
    Biochem J; 2000 Oct; 351(Pt 1):167-71. PubMed ID: 10998359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of neutral and zwitterionic 3-carboranyl thymidine analogues for boron neutron capture therapy.
    Byun Y; Yan J; Al-Madhoun AS; Johnsamuel J; Yang W; Barth RF; Eriksson S; Tjarks W
    J Med Chem; 2005 Feb; 48(4):1188-98. PubMed ID: 15715485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-nucleoside inhibitors of mitochondrial thymidine kinase (TK-2) differentially inhibit the closely related herpes simplex virus type 1 TK and Drosophila melanogaster multifunctional deoxynucleoside kinase.
    Balzarini J; Hernández AI; Roche P; Esnouf R; Karlsson A; Camarasa MJ; Pérez-Pérez MJ
    Mol Pharmacol; 2003 Feb; 63(2):263-70. PubMed ID: 12527796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and synthesis of novel imidazole-substituted dipeptide amides as potent and selective inhibitors of Candida albicans myristoylCoA:protein N-myristoyltransferase and identification of related tripeptide inhibitors with mechanism-based antifungal activity.
    Devadas B; Freeman SK; Zupec ME; Lu HF; Nagarajan SR; Kishore NS; Lodge JK; Kuneman DW; McWherter CA; Vinjamoori DV; Getman DP; Gordon JI; Sikorski JA
    J Med Chem; 1997 Aug; 40(16):2609-25. PubMed ID: 9258368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural basis of Src tyrosine kinase inhibition with a new class of potent and selective trisubstituted purine-based compounds.
    Dalgarno D; Stehle T; Narula S; Schelling P; van Schravendijk MR; Adams S; Andrade L; Keats J; Ram M; Jin L; Grossman T; MacNeil I; Metcalf C; Shakespeare W; Wang Y; Keenan T; Sundaramoorthi R; Bohacek R; Weigele M; Sawyer T
    Chem Biol Drug Des; 2006 Jan; 67(1):46-57. PubMed ID: 16492148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-based design and subsequent optimization of 2-tolyl-(1,2,3-triazol-1-yl-4-carboxamide) inhibitors of p38 MAP kinase.
    Cogan DA; Aungst R; Breinlinger EC; Fadra T; Goldberg DR; Hao MH; Kroe R; Moss N; Pargellis C; Qian KC; Swinamer AD
    Bioorg Med Chem Lett; 2008 Jun; 18(11):3251-5. PubMed ID: 18462940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substrate specificity and molecular modelling of the feline herpesvirus-1 thymidine kinase.
    Hussein IT; Miguel RN; Tiley LS; Field HJ
    Arch Virol; 2008; 153(3):495-505. PubMed ID: 18196203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.